Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy
Jiang‐Jiang Qin(ZheJiang Academy of Agricultural Sciences), Ruiwen Zhang(Center for Excellence in Molecular Cell Science)
Cited by 29
Related Papers
The MDM2-p53 pathway revisited
|Journal of Biomedical Research|2013|410
Synergistic activation of p53 by inhibition of <i>MDM2</i> expression and DNA damage
|Proceedings of the National Academy of Sciences|1998|161
Ubiquitous Induction of p53 in Tumor Cells by Antisense Inhibition of MDM2 Expression
|Molecular Medicine|1999|76
<i>In vitro</i> and <i>In vivo</i> Anticancer Activity of Novel Synthetic Makaluvamine Analogues
|Clinical Cancer Research|2009|65
Recent Advances in Validating MDM2 as a Cancer Target
|Anti-Cancer Agents in Medicinal Chemistry|2009|48